| Prev Close | 42.96 |
| Open | 44.50 |
| Day Low/High | 39.50 / 46.00 |
| 52 Wk Low/High | 13.77 / 71.50 |
| Volume | 731.82K |
BioXcel Therapeutics, Inc. (BTAI)
45.20
2.24
5.21
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 24.37B |
| Market Cap | 1.15B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Biotech M&A Picks Up: Lessons for Investors and Potential Targets
The euphoria in biotech stocks Monday was a nice change of pace. It also brought to the forefront some lessons about M&A in this industry.
This Is Great Action for Stock Pickers Right Now
Stick to themes like biotechnology, SPACs, EV batteries, and others.
2 Small Biotechs That Have Attracted My Attention and My Cash
BioXcel Therapeutics and Avadel Pharmaceuticals are new additions to my personal portfolio based on their promising drug prospects.
Stubborn Market Refuses to Budge From Uptrend
Most notable is how the coronavirus issue is having no negative impact.